Skip to search formSkip to main contentSkip to account menu

gabapentin 300 MG Oral Capsule [Neurontin]

Known as: Neurontin 300 MG Oral Capsule 
National Institutes of Health

Related topics

Related topics

12 relations
GelatinIndigo CarmineLactoseNeurontin

Broader (1)

gabapentin 300 MG Oral Capsule

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Analgesia with Gabapentin and Pregabalin May Involve N-Methyl-d-Aspartate Receptors, Neurexins, and Thrombospondins
The gabapentinoid drugs gabapentin and pregabalin (Neurontin and Lyrica) are mainstay treatments for neuropathic pain and… 
2015
2015
An acute gabapentin fatality: a case report with postmortem concentrations
Gabapentin (GBP) (Neurontin®, Horizant®, Gralise®) is a widely prescribed medication used primarily for the treatment of epilepsy… 
2015
2015
Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
Objective To explore adherence/persistence with generic gabapentin/venlafaxine versus brand-name gabapentin/venlafaxine… 
Review
2012
Review
2012
Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigation
BackgroundPrevious studies have documented strategies to promote off-label use of drugs using journal publications and other… 
2010
2010
Pharmaceutical equivalence of gabapentin tablets with various extragranular binders
Gabapentin is widely used as an oral anti-epileptic agent. However, owing to its high crystallinity and poor compaction… 
2008
2008
Chorea as a side effect of gabapentin (Neurontin®) in a patient with complex regional pain syndrome Type 1
We report the case of a woman who developed chorea in her neck, trunk, and extremities soon after taking gabapentin as treatment… 
2008
2008
La gabapentine et la prégabaline en anesthésie
Review
2004
Review
2004
A cost-utility analysis of adjunctive treatment with newer antiepileptic drugs in the UK
Summary A recent review found that economic assessment of epilepsy treatment relies largely on hypothetical modelling of outcomes… 
2001
2001
225) Open Label Trial of Oxcarbazepine in Neuropathic Pain
We evaluated the use of a new anticonvulsant, oxcarbazepine (Trileptal®, Novartis Pharmaceuticals), in 24 consecutive patients… 
1999
1999
The new generation of anti-epileptic drugs
1. Summary Epilepsy is one of the most common neurological conditions, with an estimated prevalence of 50 m people worldwide… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)